Viewing Study NCT00136604


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-03-18 @ 12:30 AM
Study NCT ID: NCT00136604
Status: COMPLETED
Last Update Posted: 2020-02-20
First Post: 2005-08-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m
Sponsor:
Organization: